Heights (Pharmaceuticals) Overview
- Year Founded
-
2013

- Status
-
Private
- Employees
-
94

- Latest Deal Type
-
2ndary - Private
- Investors
-
20
Heights (Pharmaceuticals) General Information
Description
Producer of smart supplements intended to elevate and extend cognitive performance by nourishing the brain. The company's smart supplement focuses on giving the brain the fuel it needs to improve its health performance and mental well-being, enabling customers to get the nourishment they require according to neuroscience and optimize human potential.
Contact Information
Website
www.yourheights.comCorporate Office
- 27 Old Gloucester Street
- London WC1N 3AX
- England, United Kingdom
Corporate Office
- 27 Old Gloucester Street
- London WC1N 3AX
- England, United Kingdom
Heights (Pharmaceuticals) Timeline
Heights (Pharmaceuticals) Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
13. Secondary Transaction - Private | Completed | Generating Revenue | ||||
12. Secondary Transaction - Private | 01-Jan-2023 | Completed | Generating Revenue | |||
11. Later Stage VC | 01-Oct-2022 | Completed | Generating Revenue | |||
10. Later Stage VC | 20-Dec-2021 | Completed | Generating Revenue | |||
9. Later Stage VC | 28-Jan-2021 | Completed | Generating Revenue | |||
8. Grant | 01-Oct-2020 | Completed | Generating Revenue | |||
7. Later Stage VC | 13-Feb-2018 | Completed | Generating Revenue | |||
6. Accelerator/Incubator | 05-Dec-2017 | Completed | Generating Revenue | |||
5. Early Stage VC | 03-Aug-2017 | $1.53M | $5.17M | Completed | Generating Revenue | |
4. Early Stage VC | 14-Nov-2016 | $1.88M | $3.64M | Completed | Generating Revenue |
Heights (Pharmaceuticals) Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Ordinary | ||||||||
Ordinary | ||||||||
Ordinary | ||||||||
Ordinary | ||||||||
Ordinary | ||||||||
Ordinary | ||||||||
Ordinary | ||||||||
Ordinary | ||||||||
Ordinary | 135,912 | $0.000113 | $4.17 | $4.17 | 1x | $4.17 | 1.07% | |
Ordinary | 155,918 | $0.000113 | $6.17 | $6.17 | 1x | $6.17 | 1.23% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Heights (Pharmaceuticals) Signals
Heights (Pharmaceuticals) Investors (20)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
ForGood Global | Impact Investing | Minority | ||
Downing Ventures | Venture Capital | Minority | ||
Low Carbon Innovation Fund | Venture Capital | Minority | ||
Spacestation Investments | Angel Group | Minority | ||
Chris Smalling | Angel (individual) | Minority |
Heights (Pharmaceuticals) FAQs
-
When was Heights (Pharmaceuticals) founded?
Heights (Pharmaceuticals) was founded in 2013.
-
Where is Heights (Pharmaceuticals) headquartered?
Heights (Pharmaceuticals) is headquartered in London, United Kingdom.
-
What is the size of Heights (Pharmaceuticals)?
Heights (Pharmaceuticals) has 94 total employees.
-
What industry is Heights (Pharmaceuticals) in?
Heights (Pharmaceuticals)’s primary industry is Pharmaceuticals.
-
Is Heights (Pharmaceuticals) a private or public company?
Heights (Pharmaceuticals) is a Private company.
-
What is Heights (Pharmaceuticals)’s current revenue?
The current revenue for Heights (Pharmaceuticals) is
. -
How much funding has Heights (Pharmaceuticals) raised over time?
Heights (Pharmaceuticals) has raised $13.8M.
-
Who are Heights (Pharmaceuticals)’s investors?
ForGood Global, Downing Ventures, Low Carbon Innovation Fund, Spacestation Investments, and Chris Smalling are 5 of 20 investors who have invested in Heights (Pharmaceuticals).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »